Discrepancies in the Recommended Management of Adrenal Incidentalomas by Various Guidelines.

Abstract

PURPOSE:

Adrenal incidentalomas are being discovered with increasing frequency, and their discovery poses a challenge to clinicians. Despite the 2002 National Institutes of Health consensus statement, there are still discrepancies in the most recent guidelines from organizations representing endocrinology, endocrine surgery, urology and radiology. We review recent guidelines across the specialties involved in diagnosing and treating adrenal incidentalomas, and discuss points of agreement as well as controversy among guidelines.

MATERIALS AND METHODS:

PubMed®, Scopus®, Embase™ and Web of Science™ databases were searched systematically in November 2019 in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement to identify the most recently updated committee produced clinical guidelines in each of the 4 specialties. Five articles met the inclusion criteria.

RESULTS:

There is little debate among the reviewed guidelines as to the initial evaluation of an adrenal incidentaloma. All patients with a newly discovered adrenal incidentaloma should receive an unenhanced computerized tomogram and hormone screen. The most significant points of divergence among the guidelines regard reimaging an initially benign appearing mass, repeat hormone testing and management of an adrenal incidentaloma that is not easily characterized as benign or malignant on computerized tomography. The guidelines range from actively recommending against any repeat imaging and hormone screening to recommending a repeat scan as early as in 3 to 6 months and annual hormonal screening for several years.

CONCLUSIONS:

After reviewing the guidelines and the evidence used to support them we posit that best practices lie at their convergence and have presented our management recommendations on how to navigate the guidelines when they are discrepant.

• Authors: Marissa Maas, Nima Nassiri, Sumeet Bhanvadia, John D Carmichael, Vinay Duddalwar, Siamak Daneshmand
• Journal: The Journal of urology (J Urol) Vol. 205 Issue 1 Pg. 52-59 (Jan 2021) ISSN: 1527-3792 [Electronic] United States
• PMID: 32856984 (Publication Type: Journal Article, Systematic Review)

Chemical References

• Adrenal Cortex Hormones
• Adrenergic alpha-Antagonists

Topics

• Adenoma (blood, diagnosis, pathology, therapy)
• Adrenal Cortex Hormones (blood)
• Adrenal Gland Neoplasms (blood, diagnosis, pathology, therapy)
• Adrenal Glands (diagnostic imaging, pathology)
• Adrenalectomy (standards)
• Adrenergic alpha-Antagonists (therapeutic use)
• Biopsy
• Endocrinology (methods, standards)
• Humans
• Magnetic Resonance Imaging
• Medical Oncology (methods, standards)
• Patient Preference
• Pheochromocytoma (blood, diagnosis, pathology, therapy)
• Positron-Emission Tomography
• Practice Guidelines as Topic
• Radiology (methods, standards)
• Tomography, X-Ray Computed
• Urology (methods, standards)
• Watchful Waiting (standards)